18.02.2013 Views

Tobacco and Public Health - TCSC Indonesia

Tobacco and Public Health - TCSC Indonesia

Tobacco and Public Health - TCSC Indonesia

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Introduction<br />

Chapter 7<br />

Behavioral pharmacology of nicotine<br />

reinforcement<br />

Bridgette E. Garrett, Linda Dwoskin,<br />

Michael Bardo, <strong>and</strong> Jack E. Henningfield<br />

A key feature of drug addiction is compulsive <strong>and</strong> highly controlled drug seeking <strong>and</strong><br />

self-administration, which often occur, despite the users’ awareness of harmful effects<br />

(O’Brien 1996; American Psychiatric Association 1994; World <strong>Health</strong> Organization<br />

1992). Addictive drugs, in turn, are defined in part by their ability to act as reinforcers<br />

as a result of their actions in the brain; these actions are often associated with desirable<br />

alterations of mood <strong>and</strong> feeling state (O’Brien 1996; US DHHS 1988).<br />

The 1998 U.S. Surgeon General’s conclusion that nicotine met all criteria for an<br />

addictive drug was based in part on findings that nicotine could produce (1) highly<br />

controlled or compulsive use, (2) psychoactive or mood-altering effects, <strong>and</strong> (3) that<br />

the drug functioned as a reinforcer (US DHHS 1988). The fact that tobacco use could<br />

be compulsive <strong>and</strong> that nicotine could alter mood <strong>and</strong> produce psychoactive effects<br />

had been known for centuries before the Surgeon General’s report, but the determination<br />

that it met the most stringent criteria for a reinforcer was one of the pivotal findings<br />

supporting the conclusion of the 1988 report.<br />

Underst<strong>and</strong>ing the nature <strong>and</strong> determinants of the reinforcing effects of nicotine<br />

<strong>and</strong> how these can be modulated by tobacco delivery systems is a key factor in underst<strong>and</strong>ing<br />

tobacco addiction <strong>and</strong> for developing more effective means to prevention <strong>and</strong><br />

treatment. The field of science that addresses such issues is termed ‘behavioral pharmacology’<br />

(Thompson <strong>and</strong> Schuster 1968) <strong>and</strong> a behavioral pharmacological analysis<br />

of nicotine reinforcement will be the focus of this chapter.<br />

Drug reinforcement. A drug is said to be reinforcing, or capable of producing<br />

reinforcement, when its administration can be used to strengthen behavior leading to<br />

its presentation (Thompson <strong>and</strong> Schuster 1968). This is a key behavioral pharmacological<br />

mechanism, by which highly controlled or compulsive drug use can be established<br />

namely, through the strengthening of behavior produced by the presentation of the<br />

drug. The strength of the resultant behavior is related to factors such as the chemistry<br />

of the drug itself, which can lead to controlled behavior. The reinforcing effects are

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!